Arlene Vogan

Arlene Vogan
 Position Senior Health Economist
 Org Unit Adelaide Health Technology Assessment
 Telephone +61 8 8313 6898
 Location Floor/Room WS9086.19 ,  Adelaide Health and Medical Sciences ,   North Terrace
  • Biography/ Background

    Arlene is a health economist in Adelaide Health Technology Assessment (AHTA). She is responsible for conducting and critically appraising economic evaluations of medical services, pharmaceuticals and co-dependent technologies.

  • Qualifications

    Master of Health Economics and Policy, University of Adelaide

    Graduate Certificate in Economics, University of Adelaide

    Bachelor of Science (Biomedical Science) with Honours (Genetics), University of Adelaide

  • Awards & Achievements

    Arlene was the recipient of a Society for Medical Decision Making (SMDM) - HTA Fellowship in 2014/15. SMDM partners with leading HTA organisations to provide educational and leadership opportunities for early career researchers in fields related to medical decision making.

  • Research Interests

    Arlene's research interests include health economics, health technology assessment and evidence based medicine.

  • Publications


    Carter DA, Vogan A, Haji Ali Afzali H (2016). Governments need better guidance to maximise value for money: the case of Australia's Pharmaceutical Benefits Advisory Committee. Applied Health Economics and Health Policy. DOI: 10.1007/s40258-015-0220-3


    Morona JK, Vogan A, Kessels S, Gum D, Milverton J, Parsons J, Newton S, Schubert C & Merlin T (2014). Nucleic acid amplification testing for active mycobacterial infection. MSAC Application 1234, Assessment Report. Commonwealth of Australia, Canberra, ACT.

    Parsons J, Vogan A, Morona J, Schubert C, Merlin T (2014) HbA1c testing in the diagnosis of diabetes mellitus. MSAC Application 1267, Assessment Report. Commonwealth of Australia, Canberra, ACT.

    Conference presentations

    Vogan A, Schubert C, Newton S, Merlin T (2016) What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result? Poster presentation. HTAi, Tokyo, May 10 - 14.

    Vogan A, Mitchell A, Tamblyn D, Merlin T (2015) Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster presentation. HTAi, Oslo, June 13-17.

    Vogan A, Schubert C, Parsons J, Morona J, Merlin T (2014) Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. Poster presentation. 36th Annual Meeting of the Society for Medical Decision Making, Miami, Oct 18-22.

    Vogan A, Schubert C, Parsons J, Morona J, Merlin T (2014) The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. Oral presentation. HTAi, Washington DC, June 14-18.

  • Professional Associations

    Member of Health Technology Assessment International, 2015 - 16

    Member of the Society of Medical Decision Making, 2014 - 16

    Member of the Australian Health Economics Society, 2014 - 16

    Member of ISPOR Australia Chapter Inc., 2014 - 16

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Friday, 28 Feb 2020

To link to this page, please use the following URL: